Results 181 to 190 of about 9,581,211 (349)

RECURRENT PLEURAL EFFUSION IN PRIMARY SYSTEMIC AMYLOIDOSIS – A RARE MANIFESTATION OF A RARE DISEASE

open access: diamond, 2021
Aarsh Rajesh Shah   +3 more
openalex   +1 more source

Manejo de los sistemas de drenaje pleural

open access: yesRevista Colombiana de Cirugía
El objetivo de los sistemas de drenaje pleural es la evacuación del contenido patógeno del espacio pleural. Hasta hace poco, solo se conocían y utilizaban los frascos de vidrio; sin embargo, los sistemas comerciales actuales han 'inundado' la práctica ...
Mauricio Velásquez
doaj  

Update on pleural diseases - 2007

open access: yesAnnals of Thoracic Medicine, 2007
Background : New information is available on pleural diseases. The authors selected articles to make recommendations on diagnostic and treatment aspects of pleural diseases.
Bishay Ayman   +8 more
doaj  

Clinical Outcomes of Different Generation EGFR TKIs in Susceptible EGFR‐Mutated Advanced Nonsmall‐Cell Lung Cancer

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are indicated for advanced lung adenocarcinoma patients harboring susceptible EGFR mutations. The aim of this retrospective study was to compare the effectiveness of different generations of EGFR TKIs.
Chia‐Yu Kuo   +9 more
wiley   +1 more source

Protein glycosylation in lung cancer from a mass spectrometry perspective

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi   +2 more
wiley   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Data from A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

open access: gold, 2023
Prasad S. Adusumilli   +29 more
openalex   +1 more source

Home - About - Disclaimer - Privacy